| Literature DB >> 23088559 |
Marlen Hernández-Ortiz1, Laura S Acosta-Torres, Genoveva Hernández-Padrón, Alicia I Mendieta, Rodolfo Bernal, Catalina Cruz-Vázquez, Victor M Castaño.
Abstract
BACKGROUND: Silica nanoparticles are being developed as a host of biomedical and biotechnological applications. For this reason, there are more studies about biocompatibility of silica with amorphous and crystalline structure. Except hydrated silica (opal), despite is presents directly and indirectly in humans. Two sizes of crystalline opal nanoparticles were investigated in this work under criteria of toxicology.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23088559 PMCID: PMC3549902 DOI: 10.1186/1475-925X-11-78
Source DB: PubMed Journal: Biomed Eng Online ISSN: 1475-925X Impact factor: 2.819
Figure 1XRD pattern and SEM micrographs of O1 and O2 opals. The lines present the band features of natural opal as reference and peaks marked T to tridymitic stacking.
Figure 2FTIR transmittance spectra of opals nanoparticles: a) O1 and b) O2. Identification of characteristic absorption band at 620 cm−1, attributed to the crystalline opal (opal-C) for both samples.
Figure 3EDS spectrum from the nanocrystalline particles: a) O1 opal and b) O2 opal. The chemical analysis of opal nanoparticles shows a composition of silicon and oxygen, with a few concentration of carbon of unreacted TEOS.
Figure 4Effect of opal nanoparticles on MTT reduction. Significant statistically differences not were found between groups at P > 0.05.
Figure 5Histogram of BrdU incorporation in 3T3-NIH cells. The percentage of BrdU incorporation into the cells indicates that nanocrystalline opal exposure does not show significant difference between the evaluated particles (P = 0.0931).